Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

about

Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.

P2860

Q52602016-B2357393-7833-4225-9EA6-944FBFEDAE9E

P2860

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

Item

http://www.wikidata.org/entity/Q38697736

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

@en

type

Item

label

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

@en

prefLabel

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

@en

P1476

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

@en

P2093

C L Adams

http://www.w3.org/2001/XMLSchema#string

D A Hilton

http://www.w3.org/2001/XMLSchema#string

E A Maze

http://www.w3.org/2001/XMLSchema#string

F Dave

http://www.w3.org/2001/XMLSchema#string

J Lyons-Rimmer

http://www.w3.org/2001/XMLSchema#string

R Rigby-Jones

http://www.w3.org/2001/XMLSchema#string

S Ammoun

http://www.w3.org/2001/XMLSchema#string

Y Ryan

http://www.w3.org/2001/XMLSchema#string

P2860

Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus

Physiology of the prion protein

Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier

Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases.

The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression

Redox control of prion and disease pathogenesis.

ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation.

Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation.

Axonal prion protein is required for peripheral myelin maintenance.

Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO

P2888

onc.2017.200

P304

6132-6142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2017.200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Clemens O. Hanemann

L Provenzano

P577

2017-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090571816

http://www.w3.org/2001/XMLSchema#string

P698

28692055

http://www.w3.org/2001/XMLSchema#string

P921

Prion protein family

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

about

P2860

P2860

Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921